New antiepileptic agents: strategies for drug development
- 18 August 1990
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 336 (8712) , 423-424
- https://doi.org/10.1016/0140-6736(90)91958-d
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Double‐Blind, Placebo‐Controlled Evaluation of Cinromide in Patients with the Lennox‐Gastaut SyndromeEpilepsia, 1989
- Development of New Pharmacological Agents for Epilepsy: Lessons from the Kindling ModelEpilepsia, 1989
- Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock modelsNeuropharmacology, 1988
- Antiepileptic Drug Development ProgramCleveland Clinic Journal of Medicine, 1984
- Anticonvulsant activity of (+)‐5‐methyl‐10, 11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 1982
- A NEW SERIES OF ANTICONVULSANT DRUGS TESTED BY EXPERIMENTS ON ANIMALSArchives of Neurology & Psychiatry, 1938